Lazanda
- Product NDC
- 13913-013
- 11-digit product format
- 139130013
- Labeler code
- 13913
- Product ID
- 13913-013_c2b4b455-fd85-4767-baee-4d068f08e4e7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- fentanyl citrate
- Dosage form
- SPRAY
- Route
- NASAL
- Labeler
- Depomed, Inc.
- Application
- NDA022569
- Marketing category
- NDA
- Marketing start
- 2016-01-01
- Marketing end
- 0000-00-00
- Substance
- FENTANYL CITRATE
- Active strength
- 300 ug/1
- Pharmacologic classes
- Full Opioid Agonists [MoA],Opioid Agonist [EPC]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record